446 related articles for article (PubMed ID: 12051689)
21. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
[TBL] [Abstract][Full Text] [Related]
22. [The role of methylglyoxal metabolism in type-2 diabetes and its complications].
Kender Z; Torzsa P; Grolmusz K V; Patócs A; Lichthammer A; Veresné Bálint M; Rácz K; Reismann P
Orv Hetil; 2012 Apr; 153(15):574-85. PubMed ID: 22472358
[TBL] [Abstract][Full Text] [Related]
23. [Implication of methylglyoxal in diabetes mellitus].
Artenie A; Artenie R; Ungureanu D; Haulică I; Artenie V
Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):727-32. PubMed ID: 14756009
[TBL] [Abstract][Full Text] [Related]
24. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
25. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins.
Nagaraj RH; Monnier VM
Biochim Biophys Acta; 1995 Nov; 1253(1):75-84. PubMed ID: 7492603
[TBL] [Abstract][Full Text] [Related]
26. Increased glyoxalase I levels inhibit accumulation of oxidative stress and an advanced glycation end product in mouse mesangial cells cultured in high glucose.
Kim KM; Kim YS; Jung DH; Lee J; Kim JS
Exp Cell Res; 2012 Jan; 318(2):152-9. PubMed ID: 22036650
[TBL] [Abstract][Full Text] [Related]
27. Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine.
Wilker SC; Chellan P; Arnold BM; Nagaraj RH
Anal Biochem; 2001 Mar; 290(2):353-8. PubMed ID: 11237339
[TBL] [Abstract][Full Text] [Related]
28. Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.
Wetzels S; Wouters K; Miyata T; Scheijen JLJM; Hendriks JJA; Schalkwijk CG; Vanmierlo T
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702605
[TBL] [Abstract][Full Text] [Related]
29. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
30. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
31. Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal.
Nagaraj RH; Shipanova IN; Faust FM
J Biol Chem; 1996 Aug; 271(32):19338-45. PubMed ID: 8702619
[TBL] [Abstract][Full Text] [Related]
32. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
33. Modification of vimentin: a general mechanism of nonenzymatic glycation in human skin.
Kueper T; Grune T; Muhr GM; Lenz H; Wittern KP; Wenck H; Stäb F; Blatt T
Ann N Y Acad Sci; 2008 Apr; 1126():328-32. PubMed ID: 18448838
[TBL] [Abstract][Full Text] [Related]
34. Oxidative deamination of lysine residue in plasma protein of diabetic rats. Novel mechanism via the Maillard reaction.
Akagawa M; Sasaki T; Suyama K
Eur J Biochem; 2002 Nov; 269(22):5451-8. PubMed ID: 12423343
[TBL] [Abstract][Full Text] [Related]
35. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
Chellan P; Nagaraj RH
Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
[TBL] [Abstract][Full Text] [Related]
36. Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells.
Suh KS; Choi EM; Rhee SY; Kim YS
Free Radic Res; 2014 Feb; 48(2):206-17. PubMed ID: 24164256
[TBL] [Abstract][Full Text] [Related]
37. Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications.
Metz TO; Alderson NL; Chachich ME; Thorpe SR; Baynes JW
J Biol Chem; 2003 Oct; 278(43):42012-9. PubMed ID: 12923193
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
39. Carbonyl stress and schizophrenia.
Arai M; Miyashita M; Kobori A; Toriumi K; Horiuchi Y; Itokawa M
Psychiatry Clin Neurosci; 2014 Sep; 68(9):655-65. PubMed ID: 24995521
[TBL] [Abstract][Full Text] [Related]
40. Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress.
Itokawa M; Miyashita M; Arai M; Dan T; Takahashi K; Tokunaga T; Ishimoto K; Toriumi K; Ichikawa T; Horiuchi Y; Kobori A; Usami S; Yoshikawa T; Amano N; Washizuka S; Okazaki Y; Miyata T
Psychiatry Clin Neurosci; 2018 Jan; 72(1):35-44. PubMed ID: 29064136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
